Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.
about
Excursions in polynuclear platinum DNA binding.Effects of anticancer drugs on transcription factor-DNA interactions.Platinum-based drugs: past, present and future.Different affinity of nuclear factor-kappa B proteins to DNA modified by antitumor cisplatin and its clinically ineffective trans isomer.DNA modification with cisplatin affects sequence-specific DNA binding of p53 and p73 proteins in a target site-dependent manner.Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural Factor
P2860
Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential recognition by th ...... um drug BBR3464 and cisplatin.
@en
Differential recognition by th ...... um drug BBR3464 and cisplatin.
@nl
type
label
Differential recognition by th ...... um drug BBR3464 and cisplatin.
@en
Differential recognition by th ...... um drug BBR3464 and cisplatin.
@nl
prefLabel
Differential recognition by th ...... um drug BBR3464 and cisplatin.
@en
Differential recognition by th ...... um drug BBR3464 and cisplatin.
@nl
P2093
P2860
P356
P1476
Differential recognition by th ...... num drug BBR3464 and cisplatin
@en
P2093
Jana Kasparkova
Miroslav Fojta
Nicholas Farrell
P2860
P304
P356
10.1093/NAR/GKH896
P407
P577
2004-10-14T00:00:00Z